COPD
Conditions
Interventions
Sponsors
The Second Affiliated Hospital of Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. It meets the diagnostic criteria of the Chronic Obstructive Pulmonary Disease Global Initiative 2013 Edition, and the forced expiratory volume in the first second after inhalation of bronchodilator accounts for the percentage of the predicted value (FEV1 accounts for the predicted value%) between 30% and 79%; 2. Comply with the diagnostic criteria of lung and kidney qi deficiency in the Diagnosis and Curative Effect Criteria for TCM Diseases; 3. In a stable period, no respiratory infection and acute attack of chronic obstructive pulmonary disease in the past 4 weeks; 4. Have at least 2 history of acute exacerbations or one hospitalization for acute exacerbations in the past year; 5. No other treatments were used before treatment, and no other drug clinical research was taken within one month; 6. Accept the experimental research voluntarily and sign an informed consent form. The informed consent process complies with ethical requirements.
Exclusion criteria
Exclusion criteria: 1. Asthma or other non-chronic obstructive pulmonary diseases caused by airway obstruction; 2. Patients with severe primary diseases and mental illnesses such as cardiovascular, liver, kidney and hematopoietic system; 3. Pregnant or lactating women; 4. Those who are allergic to the study drug; 5. Those who are unwilling to accept research measures or cannot cooperate for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MUC5AC;TNF-a;IL-8; | — |
Countries
China
Contacts
Public ContactLiyan Qian
The Second Affiliated Hospital of Zhejiang Chinese Medical University
Outcome results
None listed